Evio(OTC) EVIO

EVIO, Inc. is a specialized provider of analytical testing and advisory services for the cannabis industry across the United States. The company offers a comprehensive range of laboratory analyses and consulting services, ensuring compliance with regulatory standards and supporting product development.

Products and Services

• Analytical testing for cannabinoid potency and terpene profiling
• Consulting services for licensing and regulatory compliance
• Expert advisory on product formulation and strategic guidance

Growth Outlook

• Increasing demand for cannabis testing services as legalization expands
• Strategic partnerships may enhance service offerings and market reach
• Potential for revenue growth driven by industry trends and regulatory changes

Financial Highlights

• Recent quarterly revenue of 615,000, showing a positive trend
• Net income of 51,000 indicates operational improvements
• Trailing twelve months (TTM) gross profit margin at 33%, reflecting efficiency

EVIO, Inc. operates in the rapidly growing cannabis sector, providing essential services that support compliance and product quality. The company's focus on analytical testing and consulting positions it well to capitalize on the expanding market as more states legalize cannabis. Recent financial performance shows promising signs, with a notable increase in revenue and net income, suggesting effective management and operational improvements. The gross profit margin indicates a solid foundation for future growth, making EVIO an intriguing option for investors interested in the cannabis industry.